measuregroup/AID1800400

Predicate	Object
has specified output	http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID220230575_AID1800400_PMID_VALUE4 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID220230573_AID1800400_PMID_VALUE2 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID220230574_AID1800400_PMID_VALUE3 http://rdf.ncbi.nlm.nih.gov/pubchem/endpoint/SID163352116_AID1800400_PMID_VALUE1
has participant	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO00329
source	http://rdf.ncbi.nlm.nih.gov/pubchem/source/BindingDB
title	Enzyme Assay from US Patent US8691829: \"Treatment of liver disorders with PI3K inhibitors\"
type	http://www.bioassayontology.org/bao#BAO_0000040

Predicate	Subject
participates in	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID220230573 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID163352116 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID220230574 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID220230575
has measure group	http://rdf.ncbi.nlm.nih.gov/pubchem/bioassay/AID1800400

Total number of triples: 13.